Subscribe free

Newsletter

General Surgery

Best Papers in General Surgery

The five that matter, every day.

FreeNo spamOne-click unsubscribe
Ann Surg Oncol26 Aug 2026

Neoadjuvant Chemoradiation Improves Pathologic Response in ESCC

Neoadjuvant chemoradiation-immunotherapy offers better pathologic complete response rates compared to neoadjuvant chemoimmunotherapy alone in patients with locally advanced esophageal squamous cell carcinoma, but it comes with increased postoperative pulmonary complications without improving long-term survival.